CN1156613A - Chinese patent medicine for treating impotence and prospermia - Google Patents

Chinese patent medicine for treating impotence and prospermia Download PDF

Info

Publication number
CN1156613A
CN1156613A CN 96117713 CN96117713A CN1156613A CN 1156613 A CN1156613 A CN 1156613A CN 96117713 CN96117713 CN 96117713 CN 96117713 A CN96117713 A CN 96117713A CN 1156613 A CN1156613 A CN 1156613A
Authority
CN
China
Prior art keywords
gram
chinese patent
patent medicine
xuanju
draconis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 96117713
Other languages
Chinese (zh)
Other versions
CN1061868C (en
Inventor
吴荫福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN96117713A priority Critical patent/CN1061868C/en
Publication of CN1156613A publication Critical patent/CN1156613A/en
Application granted granted Critical
Publication of CN1061868C publication Critical patent/CN1061868C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A Chinese patent medicine for curing impotence and prospermia is prepared from 9 Chinese-medicinal materials such as ginseng, white atractylodes rhizome, arborvitae seed, Dragon's bone, sea horse, etc.

Description

A kind of Chinese patent medicine for the treatment of impotence and premature ejaculation
The present invention relates to a kind of Chinese patent medicine for the treatment of sexual impotence, premature ejaculation.
The Chinese patent medicine of treatment adult sexual impotence, premature ejaculation is a lot of at present, but it is slow to exist curative effect, the inapparent defective of effect, and the Chinese patent medicine formula composition, the ratio that have also exist some problems.
The present invention is exactly at the problems referred to above, provide a kind of treat sexual impotence, premature ejaculation effect significantly, the Chinese patent medicine formula of short treating period.
The objective of the invention is to finish like this: the Chinese patent medicine of treatment sexual impotence, premature ejaculation comprises Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Fructus Corni, Semen Platycladi, Os Draconis, Hippocampus, Radix Curcumae, XUANJU, Semen Ziziphi Spinosae, and these compositions are through being processed into powder.
Purpose of the present invention can be finished equally like this: in the former medicine composition of 18 grams, each composition ratio is: Radix Ginseng 1-2 gram, Rhizoma Atractylodis Macrocephalae 0.8-2 gram, Fructus Corni 0.6-1.5 gram, Semen Platycladi 0.8-1.2 gram, Os Draconis 0.6-1.6 gram, Hippocampus 1-2.5 gram, Radix Curcumae 0.6-1.2 gram, XUANJU 6.6-9 gram, Semen Ziziphi Spinosae 1-2 gram.
The present invention has following advantage:
1, cure rate height, evident in efficacy.In 279 routine sexual impotence of this medicine treatment, premature ejaculation patient, there are 276 routine full recoveries normal, cure rate reaches 99.28%.
2, short treating period, healing time are fast, and we cure sexual impotence, premature ejaculation patient, the fastest person 13 days, maximum duration person 24 days, average 18 days.
3, the curative effect scope is wide.We can not only cure sexual impotence, the premature ejaculation disease that multiple reason causes, and, poliosis old to the men and women, night, many urine, visual debility, lumbago all had significant curative effect.
4, this prescription composition science, the content ratio of each prescription is accurate.
Further add following explanation below in conjunction with embodiment, but be not limited only to following examples.
Embodiment one
1, pharmaceutical formulation: be processed into powder with Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Fructus Corni, Semen Platycladi, Os Draconis, Hippocampus, Radix Curcumae, XUANJU, Semen Ziziphi Spinosae.Each component content (in gram) in the former medicine of 18 grams: Radix Ginseng 2, the Rhizoma Atractylodis Macrocephalae 0.8, Fructus Corni 1.5, Semen Platycladi 0.8, Os Draconis 0.6, Hippocampus 2.5, Radix Curcumae 1.2, XUANJU 6.6, Semen Ziziphi Spinosae 2.
2, manufacture method: Chinese crude drug Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Fructus Corni, Semen Platycladi, Os Draconis, Hippocampus, Radix Curcumae, XUANJU, Semen Ziziphi Spinosae are dried,, pulverize and be smalls, be distributed into bag then and get final product by proportioning metering.Produce in enormous quantities, enlarge in proportion.
3, clinical result of use.With this Drug therapy sexual impotence, premature ejaculation 98 examples, through 3 course of therapy, 49 examples of fully recovering, relatively poor 1 example, total effective rate reaches 99%.
4, the using method of this medicine: take medicine each 6 grams every day 3 times.Ten days is a course of treatment, serve on three courses of treatment and imitates good.
Embodiment two
1, pharmaceutical formulation: with pure Chinese crude drug Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Fructus Corni, Semen Platycladi, Os Draconis, Hippocampus, Radix Curcumae, XUANJU, Semen Ziziphi Spinosae is that raw material is processed into powder in the former medicine composition of 18 grams: Radix Ginseng 1.5 grams, the Rhizoma Atractylodis Macrocephalae 1.5 grams, Fructus Corni 1 gram, Semen Platycladi 1 gram, Os Draconis 1 gram, Hippocampus 1.5 grams, Radix Curcumae 1 gram, XUANJU 8 grams, Semen Ziziphi Spinosae 1.5 grams.
2, manufacture method.With example one.
3, clinical result of use.With this medicine treatment sexual impotence, premature ejaculation 125 examples, through three course of therapy, 73 examples of fully recovering, produce effects 49 examples, relatively poor 3 examples, total effective rate 97.6%.
4, using method is with example one.
Embodiment three
1, pharmaceutical formulation: be processed into powder with pure Chinese crude drug Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Fructus Corni, Semen Platycladi, Os Draconis, Hippocampus, Radix Curcumae, XUANJU, Semen Ziziphi Spinosae, restrain former medicine compositions (in gram) 18: Radix Ginseng 1, the Rhizoma Atractylodis Macrocephalae 2, Fructus Corni 0.6, Semen Platycladi 1.2, Os Draconis 1.6, Hippocampus 1, Radix Curcumae 0.6, XUANJU 9, Semen Ziziphi Spinosae 1.
2, manufacture method is with example one.
3, clinical result of use.With this prescription treatment sexual impotence, premature ejaculation 87 examples through three course of therapy, 52 examples of fully recovering, produce effects 33 examples, relatively poor 2 examples, effective percentage 97.7%.
4, using method is with example one.

Claims (2)

1, resuscitation powder is characterized in that: comprise Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Fructus Corni, Semen Platycladi, Os Draconis, Hippocampus, Radix Curcumae, XUANJU, Semen Ziziphi Spinosae composition, through being processed into powder.
2, resuscitation powder according to claim 1 is characterized in that: in the former medicine composition of 18 grams, each composition ratio is
Radix Ginseng 1-2 gram,
Rhizoma Atractylodis Macrocephalae 0.8-2 gram,
Fructus Corni 0.6-1.5 gram,
Semen Platycladi 0.8-1.2 gram,
Os Draconis 0.6-1.6 gram,
Hippocampus 1-2.5 gram,
Radix Curcumae 0.6-1.2 gram,
XUANJU 6.6-9 gram,
Semen Ziziphi Spinosae 1-2 gram.
CN96117713A 1996-09-10 1996-09-10 Chinese patent medicine for treating impotence and prospermia Expired - Fee Related CN1061868C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN96117713A CN1061868C (en) 1996-09-10 1996-09-10 Chinese patent medicine for treating impotence and prospermia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN96117713A CN1061868C (en) 1996-09-10 1996-09-10 Chinese patent medicine for treating impotence and prospermia

Publications (2)

Publication Number Publication Date
CN1156613A true CN1156613A (en) 1997-08-13
CN1061868C CN1061868C (en) 2001-02-14

Family

ID=5124537

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96117713A Expired - Fee Related CN1061868C (en) 1996-09-10 1996-09-10 Chinese patent medicine for treating impotence and prospermia

Country Status (1)

Country Link
CN (1) CN1061868C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288449A (en) * 2014-07-13 2016-02-03 胡培芹 Chinese patent medicine for treating impotence and premature ejaculation
CN105311552A (en) * 2014-07-13 2016-02-10 胡培芹 Chinese patent medicine for treating impotence and premature ejaculation
CN105688049A (en) * 2016-03-07 2016-06-22 李晓晓 Traditional Chinese medicine composition for treating premature ejaculation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288449A (en) * 2014-07-13 2016-02-03 胡培芹 Chinese patent medicine for treating impotence and premature ejaculation
CN105311552A (en) * 2014-07-13 2016-02-10 胡培芹 Chinese patent medicine for treating impotence and premature ejaculation
CN105688049A (en) * 2016-03-07 2016-06-22 李晓晓 Traditional Chinese medicine composition for treating premature ejaculation

Also Published As

Publication number Publication date
CN1061868C (en) 2001-02-14

Similar Documents

Publication Publication Date Title
CN102309644A (en) Traditional Chinese medical composition for treating bone fracture
CA2467444A1 (en) Medicament for treatment of climacteric syndrome of women and preparation method thereof
CN100337667C (en) Chinese medicinal preparation for treating alopecin and early wbiteness of beard and hair
CN1134286A (en) Zhuangguning-medicine for bone fracture
CN1061868C (en) Chinese patent medicine for treating impotence and prospermia
CN101411799B (en) Oral medicinal liquor for treating rheumatism and rheumatoid disease
CN1271593A (en) Medicine for treating thyropathy
CN1500513A (en) Instant traditional Chinese medicine formulation for headache
CN116617326A (en) Traditional Chinese medicine composition for dispelling wind and relieving pain as well as preparation method and application thereof
CN1530122A (en) Chinese medicine for treating injury
CN1593566A (en) Hemiplegia treating pill
CN101530598B (en) Plaster used for hyperosteogeny
CN1054052C (en) Comedo-elimination preparation
CN1055845C (en) Dieda Huoxuesan powder for curing fracture and injury
CN1151813C (en) Traditional Chinese medicine composition for curing insomnia
CN1424077A (en) External used medicine for psoriasis
CN1048657A (en) The compound method of treatment psoriasis and tinea cruris medicament
CN1117583C (en) Medicine for curing lumbago
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN1259940C (en) Medicinal composition for treatnig bone fracture
CN101361874A (en) Sinew and bone setting-up pellet and preparation method thereof
CN1977913A (en) Chinese medicine composition fortreating gynecologic inflammation
CN1359671A (en) Process for preparing tablet for quickly setting up bone
CN1214920A (en) Gucixiao pill for removing spur
CN1061877C (en) Powder medicine (Zhuyusan) for curing dismenorrhea

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee